यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

biomarin international limited - recombinant human n-acetylgalactosamine-6-sulfatase - mucopolysaccharidose iv - andre alimentary tract and metabolism produkter, - vimizim er indiceret til behandling af mucopolysaccharidose, type iva (morquio a syndrome, mps iva) hos patienter i alle aldre.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

dompe farmaceutici s.p.a. - recombinant human nerve growth factor - keratitis - oftalmologiske - behandling af moderat (vedvarende epiteldefekt) eller alvorligt (hornhindeår) neurotrofisk keratitis hos voksne.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

biopartners gmbh - recombinant human interferon alfa-2a - hepatitis c kronisk - immunostimulants, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

celgene europe ltd. - lepirudin - thromboembolism; thrombocytopenia - antitrombotiske midler - antikoagulering hos voksne patienter med heparininduceret trombocytopeni type ii og tromboembolisk sygdom mandat parenteral antitrombotisk terapi. diagnosen skal være bekræftet af heparin-induceret blodplade aktivering analysen eller en tilsvarende test.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

dompé biotec s.p.a. - darbepoetin alfa - kidney failure, chronic; anemia; cancer - antianemiske præparater - behandling af symptomatisk anæmi forbundet med kronisk nyresvigt (crf) hos voksne og pædiatriske patienter. behandling af symptomatisk anæmi hos voksne patienter med cancer i ikke-myeloide maligniteter, der modtager kemoterapi.

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen s.a. - eplerenon - filmovertrukne tabletter - 50 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

ratiopharm gmbh - eplerenon - filmovertrukne tabletter - 25 mg

डेनमार्क - डेनिश - Lægemiddelstyrelsen (Danish Medicines Agency)

ratiopharm gmbh - eplerenon - filmovertrukne tabletter - 50 mg

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiske stoffer til suidae - svin (slagtekyllinger) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

यूरोपीय संघ - डेनिश - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - crisantaspase - forløbercellelimfoblastisk leukæmi-lymfom - antineoplastiske midler - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.